Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, Feb. 7 '26)

Image
By G.M.

 


    Antiviral Res

  1. YURGELONIS I, Rai DK, Li Z, Washington B, et al
    Analysis of Ibuzatrelvir's Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance Mutations.
    Antiviral Res. 2026 Jan 30:106352. doi: 10.1016/j.antiviral.2026.106352.
    PubMed         Abstract available


    BMJ

  2. LEI Z
    Reduced disease detection during covid-19.
    BMJ. 2026;392:s236.
    PubMed        


    Clin Infect Dis

  3. MA KC, Surie D, Dean N, Paden CR, et al
    Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness.
    Clin Infect Dis. 2026 Feb 2:ciag059. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  4. MICHELI G, Mondi A, Roen A, Taramasso L, et al
    Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?
    Int J Infect Dis. 2026 Jan 28:108437. doi: 10.1016/j.ijid.2026.108437.
    PubMed         Abstract available

  5. RUTHRICH MM, Schmitt T, Classen AY, Brandt J, et al
    Seasonal Community-Acquired Respiratory Virus Infections in Patients with Cancer - Epidemiological and Clinical Overview, an Analysis of the Multicenter OncoReVir Registry.
    Int J Infect Dis. 2026 Jan 29:108421. doi: 10.1016/j.ijid.2026.108421.
    PubMed         Abstract available

  6. KIM HK, Jin Y, Lee J, Kim YM, et al
    Facility-specific epidemiological characteristics of COVID-19 clusters across SARS-CoV-2 variant waves in South Korea.
    Int J Infect Dis. 2026 Feb 1:108450. doi: 10.1016/j.ijid.2026.108450.
    PubMed         Abstract available

  7. HO YC, Wang YT, Chou SH, Yu Liu S, et al
    Clinical outcomes of immunocompromised patients administered tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: real-world experience in Taiwan.
    Int J Infect Dis. 2026 Feb 2:108455. doi: 10.1016/j.ijid.2026.108455.
    PubMed         Abstract available

  8. GUO YX, Yang RX, Li SS, Liang B, et al
    Associations of C-reactive protein-albumin-lymphocyte (CALLY) index with severity and prognosis in COVID-19 patients.
    Int J Infect Dis. 2026 Feb 2:108459. doi: 10.1016/j.ijid.2026.108459.
    PubMed         Abstract available

  9. OGOTI B, Riitho V, Wildemann J, Mutono N, et al
    Epidemiology and genomic features of MERS coronavirus in Africa: a systematic and meta-analysis review.
    Int J Infect Dis. 2026 Feb 3:108456. doi: 10.1016/j.ijid.2026.108456.
    PubMed         Abstract available

  10. KAWASHIMA A, Tsuchiya K, Kuroki K, Nagashima M, et al
    Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Intra-host Viral Evolution in a Severely Immunocompromised Patient with Human Immunodeficiency Virus Infection: A Whole-Genome Sequencing Study.
    Int J Infect Dis. 2026 Feb 3:108453. doi: 10.1016/j.ijid.2026.108453.
    PubMed         Abstract available

  11. MASANGKAY CB, Vinarao JG, Malbas FF Jr, Quinones GJD, et al
    Comparative Evaluation of SARS-CoV-2 Antigens as Capture and Detection Elements in an In-House Antigen-Based ELISA for COVID-19 Total Antibody Detection.
    Int J Infect Dis. 2026 Feb 4:108461. doi: 10.1016/j.ijid.2026.108461.
    PubMed         Abstract available


    J Med Virol

  12. KIM J, Park H, Chua HK, Wang Y, et al
    Comparing Cross-Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort Data.
    J Med Virol. 2026;98:e70823.
    PubMed         Abstract available


    J Travel Med

  13. AL-ANSARI F, Al Ansari M, Rashid H, Al-Ansari B, et al
    Facemask use at the Arbaeen Mass Gathering during and after COVID-19 pandemic: a naked eye survey.
    J Travel Med. 2026 Jan 30:taag010. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  14. YAO Q, Mahase V, Hou W, Cruz-Cosme R, et al
    Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection.
    J Virol. 2026 Jan 30:e0146825. doi: 10.1128/jvi.01468.
    PubMed         Abstract available


    JAMA

  15. ANDERER S
    US Skilled Nursing Facility Capacity Fell 5% Since COVID-19 Pandemic.
    JAMA. 2026 Jan 30. doi: 10.1001/jama.2025.26365.
    PubMed        

  16. ABBASI J
    Mechanisms Are Emerging for COVID-19 Vaccine-Associated Myocarditis.
    JAMA. 2026 Feb 6. doi: 10.1001/jama.2025.25866.
    PubMed        


    Science

  17. BLOOMFIELD D, Black JRM, Crook O, Brandes N, et al
    Biological data governance in an age of AI.
    Science. 2026;391:558-561.
    PubMed         Abstract available

  18. NISBET EG, Manning MR
    What is causing the methane surge?
    Science. 2026;391:556-557.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »